{"id":"W4413370533","doi":"10.1093/nop/npaf061","title":"Dabrafenib in pediatric patients with <i>BRAF</i> V600 mutation–positive high-grade glioma: Results from a phase 1/2a single-arm study","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology Practice","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"Novartis Pharma; National Institute for Health and Care Research; Novartis; GlaxoSmithKline","keywords":"Dabrafenib; Glioma; Medicine; Mutation; Glioblastoma; Oncology; Internal medicine; Cancer research; Biology; Genetics; Gene; Cancer; Metastatic melanoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003043213,0.0003607459,0.0006347813,0.000582782,0.0001581888,0.00005474473,0.0001550766,0.0001878764,0.0000256266],"category_scores_gemma":[0.003039567,0.0003008214,0.00006765106,0.001412128,0.00008042068,0.0004474676,0.0001097928,0.0005701719,0.00005516124],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004289018,"about_ca_system_score_gemma":0.0003880686,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006948211,"about_ca_topic_score_gemma":0.0003966052,"domain_scores_codex":[0.9966342,0.0008136672,0.000708222,0.0009472271,0.0004794782,0.0004171717],"domain_scores_gemma":[0.9919562,0.006399884,0.0005390226,0.0005428125,0.0003858843,0.0001762422],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04886393,0.4269101,0.442856,0.00005222788,0.001309181,0.04722203,0.005874763,0.0001019687,0.005030412,0.0001398359,0.007211765,0.01442781],"study_design_scores_gemma":[0.2283354,0.03849083,0.7103595,0.0000903537,0.005556033,0.0001639266,0.001888569,0.00003958504,0.007597432,0.00006304149,0.006948486,0.0004668531],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9839743,0.0001704671,0.00001459376,0.009475553,0.0005766578,0.002543875,0.0001843646,0.00009365783,0.00296656],"genre_scores_gemma":[0.9950629,0.00003503895,0.001009834,0.002992884,0.0001556177,0.0002754729,0.0004088338,0.0000386583,0.00002079169],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3884192,"threshold_uncertainty_score":0.9999444,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0164763583988484,"score_gpt":0.3175267917357269,"score_spread":0.3010504333368785,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}